Effect of Antiepileptic Drugs on Bone Mineral Density in Children Between Ages 6 and 2 Years
- 1 March 1999
- journal article
- research article
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 38 (2), 93-98
- https://doi.org/10.1177/000992289903800205
Abstract
We assessed the effects of sodium valproate and carbamazepine monotherapy on bone mineral density (BMD) in children. BMD at the lumbar vertebrae (L1-L4) and radius-ulna was measured by the dual-energy x-ray absorptiometry (DEXA) method in 19 children (9 girls, 10 boys) with uncomplicated epilepsy and in 57 healthy children (28 girls, 29 boys), between the ages of 6 and 12 years. The study patients had been receiving either sodium valproate (n=13) or carbamazepine (n=6) monotherapy for more than 6 months. There were no significant differences between the control and study patients in age, height, weight, physical activity, or of serum concentrations of calcium, phosphate, and transaminases (aspartate aminotransferase, alanine aminotransferase). However, the serum alkaline phosphatase concentration was greater in the patient group as compared with the control group. BMD values were lower in girl patients (L1-L4; 0.497 0.08 vs 0.566 0.07 g/cm2, p2). While BMD reduction was 8% in valproate therapy (midregion of radius-ulna; 0.287.03 vs 0.312 04 g/cm2, p2, statistically not significant), although the mean durations of monotherapy with valproate (1.8 7 years) and carbamazepine (1.7 8 years) were similar. Thus decreased bone mineralization was observed in children with epilepsy, treated with sodium valproate even though treatment was for a rather short time.Keywords
This publication has 16 references indexed in Scilit:
- Effect of carbamazepine and valproate on bone mineral densityThe Journal of Pediatrics, 1995
- The effects of anticonvulsant drugs on vitamin D3-activating cytochrome P-450-linked monooxygenase systemsThe Journal of Steroid Biochemistry and Molecular Biology, 1991
- Phenytoin affects osteocalcin secretion from osteoblastic rat osteosarcomaBone, 1990
- Bone Status in Nonambulant, Epileptic, Institutionalized YouthClinical Pediatrics, 1988
- Long-Term Anticonvulsant Therapy and Vitamin D Metabolism in Ambulatory Pubertal ChildrenNeuropediatrics, 1986
- Involutional OsteoporosisThe New England Journal of Medicine, 1986
- Fractures caused by epileptic seizures and epileptic osteomalaciaInjury, 1986
- Does carbamazepine cause disturbances in calcium metabolism in epileptic patients?Acta Neurologica Scandinavica, 1983
- Serum alkaline phosphatase and urinary hydroxyproline values in children receiving phenobarbital with and without vitamin DThe Journal of Pediatrics, 1975
- Incidence of Anticonvulsant Osteomalacia and Effect of Vitamin D: Controlled Therapeutic TrialBMJ, 1973